Timothy Zgleszewski, MD
Sports Medicine · North Charleston, SCNPI 1609833516
Payments from drug & device makers
Across 68 payments — averaging $17.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Scilex Pharmaceuticals Inc.$144
- Assertio Therapeutics, Inc.$135
- Boston Scientific$131
- Forte Bio-pharma LLC$108
- Zyla Life Sciences, Inc.$67
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$65
- plus $515 from 17 others
What the payments were for
- Food & beverage$1,166100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Scilex Pharmaceuticals Inc. | 8 | $144 |
| Assertio Therapeutics, Inc. | 9 | $135 |
| Boston Scientific | 5 | $131 |
| Forte Bio-pharma LLC | 6 | $108 |
| Zyla Life Sciences, Inc. | 5 | $67 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $65 |
| Nevro Corp. | 3 | $64 |
| Fidia Pharma USA Inc. | 5 | $63 |
| Averitas Pharma Inc. | 2 | $50 |
| Avanos Medical | 3 | $45 |
| Pfizer | 3 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Orthogenrx Inc. | 2 | $34 |
| Pernix Therapeutics Holdings, Inc. | 2 | $25 |
| Abbott | 1 | $24 |
| Medtronic | 1 | $21 |
| Tonix Medicines, Inc. | 1 | $20 |
| Vertex | 1 | $20 |
| Biodelivery Sciences International, Inc. | 1 | $15 |
| Novo Nordisk | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $13 |
| Shionogi Inc | 1 | $12 |
| Collegium Pharmaceutical, Inc. | 1 | $12 |
How this compares
$1,166 in reported general payments places this provider in the 45th percentile of 158 sports medicine providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 235 | $5,411 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 124 | $3,874 |
| Oxycodone Hcl | 79 | $1,376 |
| Morphine Sulfate ErMorphine Sulfate | 25 | $548 |
| Gabapentin | 36 | $538 |
| Pregabalin | 12 | $317 |
| Baclofen | 17 | $133 |
| Tramadol Hcl | 12 | $43 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in North Charleston
- Silas HolmesColumbia$2.2M
- Stephan PillGreenville$858K
- Michael KissenberthGreenville$765K
- Stefan TolanGreenville$471K
- Guillaume DumontWest Columbia$365K
- Steven MartinSeneca$356K
- Douglas WylandSpartanburg$171K
- Jeffrey GuyColumbia$120K
- Harris SloneCharleston$98K
- Donovan JohnsonConway$56K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.